Phase 1 T Cells Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas

Peripheral T Cells Lymphoma (PTCL)

The Lymphoma Academic Research Organisation49 enrolled20 locationsNCT07018752

Recruiting

Phase 1Phase 2

Polyspecific Antibodies in Lymphoproliferative T-cell Disorders

Peripheral T Cells Lymphoma (PTCL)

Xenothera SAS54 enrolled8 locationsNCT06495723